Picture of Integral Diagnostics logo

IDX — Integral Diagnostics News Story

0.000.00%
au flag iconLast trade - 00:00
HealthcareBalancedMid CapSuper Stock

Brief: Integral Diagnostics Sees FY23 Replacement And Growth Capex Between A$30Mln To A$40Mln

Nov 4 (Reuters) - Integral Diagnostics Ltd  IDX.AX :
    * FY23 REPLACEMENT AND GROWTH CAPEX IS EXPECTED TO BE
BETWEEN
A$30MLN TO A$40MLN

Source text for Eikon:  ID:nASX69w8HT 
Further company coverage:  IDX.AX 
 ((Reuters.Briefs@thomsonreuters.com;))

Recent news on Integral Diagnostics

See all news